Green Biologics Ltd. (GBL) is a leading industrial biotechnology company focused on the production of renewable n-butanol and other C4 chemicals from various renewable feedstocks, including sugar (cane, molasses, beets), starch (corn) and cellulosic biomass (corn residues, sugar cane bagasse, forest materials and grasses). We work with feedstock partners to deliver capital efficient production models, and we work with downstream partners to deliver high quality, competitively priced products. Our focus is on the global renewable chemicals and biofuels markets.
GBL has developed a full range of proprietary technologies around a core Clostridia fermentation platform including superior and metabolically engineered strains together with advanced high productivity fermentation. GBL works closely with partners on pre-treatment and hydrolysis of cellulosic feedstocks.
GBL utilizes advanced biotechnology to manufacture high value C4 chemicals and biofuels from renewable sources of carbon. Our primary product is renewable normal butanol, or n-Butanol, along with its co-product acetone. We also have the technology to produce butyric acid, and we are actively working on other high value chemicals using our library of proprietary Clostridia and thermophilic strains.
GBL's technology and products are sought after in a variety of growing global markets totalling over $900 billion, including the $85 billion paints, coatings, adhesives and inks market, the $40 billion animal nutrition market, and the $700 billion plastics and polymers market. As a fuel blend stock alone, biobutanol is an $80 billion market opportunity, or 40 billion gallons per year.